1. The Centers for Disease Control (CDC), Division of Bacterial and Mycotic Disease:

http://www.cdc.gov/ncidod/dbmd/diseaseinfo/candidiasis_t.htm

 

2. The Centers for Disease Control (CDC), Division of Bacterial and Mycotic Disease:

http://www.cdc.gov/ncidod/dbmd/diseaseinfo/candidiasis_gen_g.htm

 

3. Elmer GW, et al. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. Mar1996;275(11):870-6.
 

4. Hilton E, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. Mar1992;116(5):353-7.
 

5. Fitzsimmons N, Berry DR. Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios. 1994;80(323):125-33.
 

6. Jack M, et al. Evidence for the involvement of thiocyanate in the inhibition of Candida albicans by Lactobacillus acidophilus. Microbios. 1990;62(250):37-46.
 

7. Saavedra, J.M. Clinical applications of probiotic agents. Am. J. Clin. Nutr. 2001 Jun; 73(6): 1147S-1151S.

 

8. Visioli F, et al. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci 62 (6) (1998): 541-6.

 

9. Bisignano G,  et al. "On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J Pharm Pharmacol. 51 (6) (1999): 971-4

 

10. Visioli F. Antiatherogenic components of olive oil. Curr Atheroscler Rep. Jan2001;3(1):64-7.
 

11. Heinze JE, et al. Specificity of the antiviral agent calcium elenolate. Antimicrob Agents Chemother. Oct1975;8(4):421-5.
 

12. Ionescu G, et al. Oral Citrus seed extract. J Orthomolecula Med. 1990;5(3):72-74.

 

13. Arimi SM. Campylobacter infection in humans.East Afr Med J. Dec1989; 66 (12):851-5.

 

14. Sandoval CM, et al.   Cat's claw inhibits TNFalpha production and scavenges free radicals: role in cytoprotection. Free Radic Biol Med. 2000 Jul 1;29(1):71-8.          
 

15. Lamm S, Sheng Y, Pero RW. Persistent response to pneumococcal vaccine in individuals supplemented with a novel water soluble extract of Uncaria tomentosa, C-Med-100. Phytomedicine. Jul2001;8(4):267-74.

 

16. Lemaire I, Assinewe V, Cano P, Awang DV, Arnason JT. Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (una de gato). J Ethnopharmacol. Feb1999;64(2):109-15.

 

17. Aquino R, et al. Plant Metabolites. Structure and in Vitro Antiviral Activity of Quinovic Acid Glycosides from Uncaria tomentosa and Guettarda platypoda. J Nat Prod. 1989;52(4):679-85.
 

18. Aquino R, et al. Plant Metabolites. New Compounds and Anti-inflammatory Activity of Uncaria tomentosa. J Nat Prod. 1991;54(2):453-59.
 

19. Sandoval-Chacon M. Antiinflammatory actions of cat's claw: the role of NF-kappaB. Aliment Pharmacol Ther. Dec1998;12(12):1279-89.
 

20. Dorman HJ, et al. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol. Feb2000;88(2):308-16.
 

21. Force M, et al. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res. May2000;14(3):213-4.

 

22. Lamaison JL, et al. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm Acta Helv. 1991;66(7):185-8.
 

23. Marino, M., Bersani, C., Comi, G. Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int. J. Food Microbiol. 2001 Aug 5; 67(3): 187-95.

 

24. Hammer KA et al. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol. 1999 Jun;86(6):985-90.         
 

25. Somerville K et al. Delayed release peppermint oil capsules (copermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol 1984 (18): 648-40.

 

26. May B et al. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneim forsch 1996 (46): 1149-53.

 

27. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 311

 

28. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 310

 

29. Sack RB et al. Berberine inhibits intestinal secretory response of vibrio cholerae toxins and escherichia coli enterotoxins. Infect Immun 1982 (35): 471-5.

 

30. Khin-Maung U et al. Clinical trial of berberine in acute watery diarrhoea. Br Med J 1985 (291):1601-5.

 

31. Rabbani GH et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic escherichia coli and vibrio cholerae. J Infect Dis 1987 (155): 979-84.

 

32. Kaneda Y et al. In vitro effects of berberine sulfate on the growth of entamoeba histolytica, Giardia lamblia, and Trichomonas vaginalis. Annals Trop Med Parasitol 1991 (85): 417-25.

 

33. Steiner M, et al. A Double-blind Crossover Study in Moderately Hypercholesterolemic Men that Compared the Effect of Aged Garlic Extract and Placebo Administration on Blood Lipids. Am J Clin Nutr. 1996;64(6):866-70.
 

34. Agarwal KC. Therapeutic Actions of Garlic Constituents. Med Res Rev. 1996;16(1):111-24

 

35. Adetumbi M, et al. Allium sativum (Garlic)--A Natural Antibiotic. Med Hypoth. 1983;12:227-37.
 

36. Pai ST, et al. Antifungal Effects of Allium sativum (Garlic) Extract Against the Aspergillus Species Involved in Otomycosis. Lett Appl Microbiol. 1995;20(1):14-18.

 

37. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 310

 

38. Mann CM, et al. The outer membrane of pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil of melaleuca alternifolia. Lett Appl Microbiol. Apr2000;30(4):294-7.
 

39. Carson CF, et al. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother. Mar1995;35(3):421-4.
J Antimicrob Chemother. 1998 Nov;42(5):591-5.                    

 

40. Hammer KA et al.  In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Appl Bacteriol. 1995 Mar;78(3):264-9.

 

41. Nenoff P, et al. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol. 1996;9(6):388-94.
 

42. Tong MM, et al. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol. 1992;33(3):145-9.
 

43. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 309

 

44. Hauer J, et al. Mechanism of Stimulation of Human Natural Killer Cytotoxicity by Arabinogalactan from Larix occidentalis. Cancer Immunol Immunother. 1993;36(4):237-44.
 

45. Bhimani, R.S., Vendrov, Y., Furmanski, P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J. Appl. Microbiol. 1999 Jan; 86(1): 135-44.

 

46. Dial, E.J., Hall, L.R., Serna, H., Romero, J.J., Fox, J.G., Lichtenberger, L.M. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig. Dis. Sci. 1998 Dec; 43(12): 2750-6.

 

47. Haversen, L.A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L.A., Mattsby-Baltzer, Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun. 2000 Oct; 68(10): 5816-23.

 

48. Kuwata, H., Yip, T.T., Tomita, M., Hutchens, T.W. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta 1998 Dec 8; 1429(1): 129-41.

 

49. Kruzel, M.L., Harari, Y., Chen, C.Y., Castro, G.A. The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. Adv. Exp. Med. Biol. 1998; 443: 167-73.

 

50. Rubinstein E et al. Antibacterial activity of the pancreatic fluid. Gastroenterol 1985 (88): 927-32.

 

51. Sarker SA et al.  Non-immunological defense mechanisms of the gut. Gut 1990 (33): 1331-7.

 

52. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 306